Insight Lifetech Co., Ltd. (SHSE: 688712)
Health Care · Health Care Equipment & Supplies · CN
CN¥34.72
-0.29% today · -30.1% 1Y
Insight Lifetech Co., Ltd. (SHSE: 688712) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $2.15B and employs 673 people.
Over the last twelve months the share price has lost 30.1%, trading between 30.72 and 55.80.
Tweenvest scores Insight Lifetech Co., Ltd. across four factors: quality 63/100, growth 100/100. Its strongest factor is growth.
688712 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.15B
- Revenue (TTM)
- $86.98M
- P/E
- 126.08
- EPS
- 0.28
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CN¥55.80
- 52-week low
- CN¥30.72
- Avg volume (3M)
- —
- Shares outstanding
- 417.00M
- Employees
- 673
- Next earnings
- —
About Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. operates as a medtech company. Its products include coronary physiology, coronary imaging, and coronary catheters. The firm also offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu, Song Liang and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China.
- Founded
- 2015
- Listed since
- Feb 5, 2026
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.